RxDoctor Payments Data

Josue Munoz

Psychiatric/Mental Health · Houston, TXNPI 1457858003

Payments from drug & device makers

$2,997in general payments, 2019–2025

Across 130 payments — averaging $23.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$774
  • Neurocrine Biosciences, Inc.$293
  • Otsuka America Pharmaceutical, Inc.$285
  • AbbVie$277
  • Johnson & Johnson$275
  • Teva Pharmaceuticals USA, Inc.$187
  • plus $907 from 12 others

What the payments were for

  • Food & beverage$2,95098%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,997 in reported general payments places this provider in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas

Medicare billing

Part B allowed, 2024
$61,686
Medicare patients
35
Services billed
837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl67$87,181
Modafinil13$3,734
Aripiprazole31$2,043
Quetiapine Fumarate ErQuetiapine Fumarate34$1,417
Quetiapine Fumarate40$1,053
Doxepin Hcl11$967
Bupropion XlBupropion Hcl31$787
Desvenlafaxine Succinate ErDesvenlafaxine Succinate28$594
Buspirone Hcl54$550
Duloxetine Hcl27$409
Lithium Carbonate ErLithium Carbonate36$396
Escitalopram Oxalate65$387
Fluoxetine Hcl16$342
Venlafaxine Hcl ErVenlafaxine Hcl35$340
Sertraline Hcl90$293

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$275$87,18167 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →